Status:
UNKNOWN
Immunogenetics Predictors With COVID-19
Lead Sponsor:
Mansoura University
Conditions:
Genetic Predisposition to Disease
Eligibility:
All Genders
18+ years
Brief Summary
Background: There is a current worldwide outbreak of the novel coronavirus Covid-19 which originated from Wuhan in China and has now spread to 6 continents including 210 countries. There is still a la...
Detailed Description
There is a current worldwide outbreak of the novel coronavirus Covid-19 (coronavirus disease 2019; the pathogen called SARS-CoV-2; previously 2019-nCoV), which originated from Wuhan in China and has n...
Eligibility Criteria
Inclusion
- Adult subjects (\> 18 years old) with COVID 19 infection.The patients will be classified on the basis of the severity of the disease.
Exclusion
- -patients have symptoms of fever and /or respiratory with negative PCR for COVID-19.
Key Trial Info
Start Date :
September 10 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 9 2022
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04390269
Start Date
September 10 2020
End Date
May 9 2022
Last Update
February 24 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mansoura Faculty of Medicine
Al Mansurah, Dakahlyia, Egypt, 35516